About Zhuhai Rundu Pharma
Zhuhai Rundu Pharmaceutical Co., Ltd is a modern high-tech enterprise integrating R&D, production and marketing. Company’s registered capital is 75 million Yuan with more than 800 employees.Our company focuses on integrity management, taxes actively, AAA level bank credit, top 30 private enterprises of taxpayers in Zhuhai City. Now Rundu Pharma has been an influential enterprise in domestic market of peptic ulcer disease medication and antihypertensive medication, a leading enterprise of producing sustained & controlled pellets and enteric-coated pellets.
Our products cover the fields of cardio-cerebral blood vessels, digestion and anesthesia owning over 50 production licenses and more than 10 certifications of new medicines. Our company pays high attention on product quality and established national GMP certified workshops. Piperaquine Phosphate has obtained WHO GMP;Valsartan and Irbesartan have completed the registration of Russian and Korean FDA;Candesartan Cilexitil and Olmesartan Medoxomil have obtained CEP certificate.Candesartan Cilexitil has passed PMDA audit.
We are dedicated to healthy life by serving patients with formulation and API of best quality both domestic and international, with our extending pipeline. At Rundu, we believe in sustainable growth, by both building our in-house R&D capabilities, and together with our partners via flexible modes like license-in/out, technology transfer, co-development, CMO, CDMO, CRO, CSO and so on.
National High-tech Enterprise
Key High-tech Enterprise of China Torch Program
National Postdoctoral Research Station
Innovation-based Enterprise in Guangdong
Enterprise Technical Centers in Guangdong
Engineer Technology R&D Center of Sustained-release Pellet Preparation in Guangdong